Marshall Wace North America’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-9,545
| Closed | -$246K | – | 1337 |
|
|
2021
Q1 | $246K | Sell |
9,545
-418,902
| -98% | -$10.8M | ﹤0.01% | 1325 |
|
|
2020
Q4 | $22.9M | Sell |
428,447
-790,742
| -65% | -$42.3M | 0.1% | 220 |
|
|
2020
Q3 | $50.3M | Buy |
1,219,189
+1,194,767
| +4,892% | +$49.3M | 0.32% | 74 |
|
|
2020
Q2 | $1.18M | Buy |
+24,422
| New | +$1.18M | 0.01% | 718 |
|
|
2020
Q1 | – | Sell |
-31,115
| Closed | -$1.33M | – | 1178 |
|
|
2019
Q4 | $1.33M | Buy |
+31,115
| New | +$1.33M | 0.01% | 665 |
|
|
2018
Q3 | – | Sell |
-198,214
| Closed | -$3.03M | – | 889 |
|
|
2018
Q2 | $3.03M | Buy |
+198,214
| New | +$3.03M | 0.02% | 649 |
|